EUVIMEDEUVIMED entdecken
Qualitative StudieOpen Access · CC BY 4.0

Hydromorphone Hopes: A Qualitative Study of People Initiating Supervised Short‐Acting Injectable Opioid Treatment in Australia

Jake Rance iD, Vendula Belackova, James Bell iD, Adrian J Dunlop iD, Nadine Ezard iD, Marianne Jauncey, Nicholas Lintzeris iD, Eugenia Oviedo-Joekes iD, Alison Ritter iD, Darren M Roberts, Craig Rodgers, Krista J Siefried iD und 3 weitere

Drug and Alcohol Review · 2025

DOI: 10.1111/dar.14092 ↗

Kurz gefasst

Qualitative Studie in der Zeitschrift Drug and Alcohol Review, 2025. Verfasst von Jake Rance und 14 weiteren Autor:innen. Beteiligte Einrichtung: UNSW Sydney, Sydney, Australia. Hauptthemen laut MEDLINE: Hydromorphone, Analgesics, Opioid, Opioid-Related Disorders, Opiate Substitution Treatment. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: St Vincent's Hospital Sydney, Uniting NSW/ACT, National Health and Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

A growing body of qualitative scholarship has drawn attention to aspects of supervised injectable opioid treatment (SIOT) not captured in earlier clinical trial data, identifying treatment initiation as one such area. Crucial questions surrounding people's motivations, expectations and initial experiences of SIOT remain under‐explored. This paper examines the first tranche of qualitative findings from participants of Australia's first‐ever SIOT trial, the ‘Feasibility of Opioid Injectable Treatment’ (FOpIT) study. Noting the novelty of both SIOT and hydromorphone within the Australian context, we ask: what motivated people to participate in the trial and what were their early experiences of this new treatment and medication?

Methods

Fifteen semi‐structured, in‐depth qualitative interviews were conducted with participants commencing hydromorphone.

Results

Almost universally, participants expressed a strong desire for change in their lives, foregrounding their intention to cease or reduce their use of street heroin. For many, the appeal of SIOT was driven by prior, unsatisfactory experiences with standard opioid agonist treatment (methadone, buprenorphine). Early accounts of hydromorphone ranged from favourable comparisons to street heroin to noting its relative shortcomings. Nonetheless, a dominant narrative emerged of reduced or ceased use of street heroin within days of beginning the trial. Discussion and Conclusions Understanding the complexities surrounding SIOT initiation has clear implications for clinical practice, including the potential for improved treatment engagement, retention and outcomes. Accounts from FOpIT participants commencing SIOT revealed a diversity of motivations, hopes, goals and medication effects. The extent to which these are carried through to treatment outcomes is an area of ongoing research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HydromorphoneAnalgesics, OpioidOpioid-Related DisordersOpiate Substitution TreatmentHumansAustraliaMaleFemaleAdultQualitative ResearchMiddle AgedMotivationInjections

Stichwörter der Autor:innen

Australiahydromorphoneimplementation trialqualitative studysupervised injectable opioid treatmenttreatment initiation

Substanzen

HydromorphoneAnalgesics, Opioid

Autor:innen und Institutionen

  • UNSW Sydney, Sydney, Australia.
  • National Addiction Centre, King's College London, London, UK.
  • Drug and Alcohol Clinical Services Research, Hunter New England Health, Newcastle, Australia.
  • The University of Newcastle & Hunter Medical Research Institute, Newcastle, Australia.
  • Alcohol and Drug Service, St Vincent's Hospital Sydney, Sydney, Australia.
  • Uniting MSIC, Sydney, Australia.

ORCID-Profile: Jake Rance, James Bell, Adrian J Dunlop, Nadine Ezard, Nicholas Lintzeris, Eugenia Oviedo-Joekes, Alison Ritter, Krista J Siefried, Carla Treloar

Förderung

  • St Vincent's Hospital Sydney
  • Uniting NSW/ACT
  • National Health and Medical Research Council

Zitieren

APA

Rance, J., Belackova, V., Bell, J., Dunlop, A. J., Ezard, N., Jauncey, M., Lintzeris, N., Oviedo-Joekes, E., Ritter, A., Roberts, D. M., Rodgers, C., Siefried, K. J., Strang, J., van den Brink, W., & Treloar, C. (2025). Hydromorphone Hopes: A Qualitative Study of People Initiating Supervised Short‐Acting Injectable Opioid Treatment in Australia. Drug and Alcohol Review. https://doi.org/10.1111/dar.14092

Vancouver

Rance J, Belackova V, Bell J, Dunlop AJ, Ezard N, Jauncey M, et al. Hydromorphone Hopes: A Qualitative Study of People Initiating Supervised Short‐Acting Injectable Opioid Treatment in Australia. Drug and Alcohol Review. 2025. doi:10.1111/dar.14092

BibTeX
@article{Rance2025,
  author = {Rance, Jake and Belackova, Vendula and Bell, James and Dunlop, Adrian J and Ezard, Nadine and Jauncey, Marianne and Lintzeris, Nicholas and Oviedo-Joekes, Eugenia and Ritter, Alison and Roberts, Darren M and Rodgers, Craig and Siefried, Krista J and Strang, John and van den Brink, Willem and Treloar, Carla},
  title = {Hydromorphone Hopes: A Qualitative Study of People Initiating Supervised Short‐Acting Injectable Opioid Treatment in Australia},
  journal = {Drug and Alcohol Review},
  year = {2025},
  doi = {10.1111/dar.14092}
}
Kostenlos starten →